<DOC>
	<DOC>NCT02521857</DOC>
	<brief_summary>This study will evaluate the impact of water consumption on the pharmacokinetics of ALKS 5461.</brief_summary>
	<brief_title>A Water Consumption Study of ALKS 5461 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Has a body mass index (BMI) of 18.0 30.0 kg/m^2 Is in good physical health Agrees to use an approved method of contraception for the duration of the study Additional criteria may apply Is currently pregnant or breastfeeding Has a history of substance abuse disorder Has used nicotine within 90 days prior to the study or anticipates a need to use nicotine during the study period Has used any prescription or overthecounter medication, including natural health products or dietary supplements (with the exception of prescription contraceptives or hormonal replacements, acetaminophen, ibuprofen, or multivitamins) within 14 days prior to study start Has used opioids within 30 days prior to screening, or has an anticipated need for opioid medication at any point during the study Has used alcohol within 72 hours prior to any inpatient period Is a heavy caffeine drinker (regularly consuming 5 or more caffeinated beverages per day) Has a history of intolerance or hypersensitivity to opioids (buprenorphine) or opioid antagonists (naltrexone, naloxone) Additional criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Alkermes</keyword>
	<keyword>Samidorphan</keyword>
	<keyword>ALKS 5461</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>